scholarly journals Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes

2020 ◽  
Author(s):  
2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Heather Klocke ◽  
Zhao Ming Dong ◽  
Craig O’Brien ◽  
Nicholas Burwick ◽  
Robert E. Richard ◽  
...  

T/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS) is an uncommon and aggressive leukemia without well-established treatment guidelines, particularly when relapsed. Venetoclax plus a hypomethylating agent offers a promising option in this situation since studies support its use in both acute myeloid and, albeit with fewer data to date, acute T-cell-lymphoblastic leukemias. We report the successful eradication of T/myeloid MPAL NOS relapsed after allogeneic stem cell transplant with venetoclax plus decitabine. A consolidative allogeneic stem cell transplant from a second donor was subsequently performed, and the patient remained without evidence of disease more than one year later. Further investigation is indicated to evaluate venetoclax combined with hypomethylating agents and/or other therapies for the management of T/myeloid MPAL NOS.


2018 ◽  
Vol 57 (8) ◽  
pp. 1155-1158 ◽  
Author(s):  
Teruhito Takakuwa ◽  
Takahiko Nakane ◽  
Masahiko Ohsawa ◽  
Joji Nagasaki ◽  
Yasutaka Aoyama ◽  
...  

Author(s):  
Behzad Poopak ◽  
Adnan Khosravi ◽  
Gholamreza Bahoush-Mehdiabadi ◽  
Tahereh Madani ◽  
Elahe Khodadi ◽  
...  

2017 ◽  
Vol 59 (5) ◽  
pp. 1231-1238 ◽  
Author(s):  
Aparna Pallavajjala ◽  
Daehwan Kim ◽  
Tongbin Li ◽  
Gabriel Ghiaur ◽  
Richard J. Jones ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document